Attribution

LOT 5: Pharmacoepidemiological research

Name: LOT 5: Pharmacoepidemiological research
Creator: European Medicines Agency, MED - European Medicines Agency
Published: 2026-09-01
License: https://ted.europa.eu/en/simap/legal-notice

Suivre cette ficheCompte gratuit — soyez alerté dès qu’un marché arrive à échéance.

Acheteur: European Medicines Agency, MED - European Medicines Agency
Titulaires: Agora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL, Critical Path Institute – Stichting, Danish medicines Agency, EPICONCEPT, ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM, Fundacion Publica Miguel Servet, Instituto Nacional de Saude Dr. Ricardo Jorge, IQVIA Solutions bv, MYO Health Policy Advisors P.C., OM1 bv, P95 bv, Panepistimio Patron, Quinten Health SAS, Universiteit Utrecht, University Medical Center Utrecht, Vaccine Monitoring Collaboration for Europe
Montant du marché: aucun montant publié
Offres reçues: 14
Publié le: 1 sept. 2026
Attribution: 17 mars 2026
Début d'exécution: 17 mars 2026
Fin du marché: 14 févr. 2028estimée
Secteur: Recherche et développement
Région: Groot-Amsterdam
Source: Avis d'origine sur TED (606784-2026)

Autres attributions de cet acheteur

Attribution	Acheteur	Titulaire	Montant du marché	Publié le
Data Management- Anonymization and redaction of documents and datasets	European Medicines Agency, MED - European Medicines Agency	IQVIA Solutions Belgium B.V., Syneos Health Clinical Spain, S.L.U.	—	4 sept. 2026
LOT 7: Computational methods for comparison of molecular structural features in the context of medicines for rare diseases	European Medicines Agency, MED - European Medicines Agency	Istituto di Ricerche Farmacologiche Mario Negri, KREATIS	—	1 sept. 2026
LOT 6: Innovative technologies for manufacturing and quality control of medicines	European Medicines Agency, MED - European Medicines Agency	NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED, RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH, UNIVERSITA DEGLI STUDI DI MILANO	—	1 sept. 2026
LOT 4: Qualitative research	European Medicines Agency, MED - European Medicines Agency	NHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres	—	1 sept. 2026
LOT 3: Methodological/statistical research	European Medicines Agency, MED - European Medicines Agency	Agentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres	—	1 sept. 2026
LOT 2: Veterinary research	European Medicines Agency, MED - European Medicines Agency	Danish medicines Agency, ECORYS EUROPE EEIG - GEIE, Gent university	—	1 sept. 2026